25 devices · GMDN 57534
Progesterone receptor in vitro diagnostic (IVD) antibody devices are laboratory tools designed to detect the presence or concentration of progesterone receptors in tissue samples. Clinically, they help assess hormone receptor status in conditions like breast cancer, guiding treatment decisions such as hormone therapy eligibility or resistance prediction.
These devices are typically regulated as IVDs, with classification and supply depending on jurisdiction-specific requirements. They are used in research or clinical settings and must meet performance standards for accuracy and reliability in receptor detection, though regulatory pathways vary by country.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.